Results 31 to 40 of about 129,287 (247)

Adenosquamous Carcinoma of the Choledochus

open access: yesCase Reports in Gastroenterology, 2019
The patient was an 86-year-old man who was admitted with obstructive jaundice. Computed tomography revealed a tumor in the hilar choledochus with peripheral hepatic duct dilatation.
Daisuke Uehara   +12 more
doaj   +1 more source

Development of a minigenome cassette for Lettuce necrotic yellows virus: A first step in rescuing a plant cytorhabdovirus [PDF]

open access: yes, 2020
Rhabdoviruses are enveloped negative-sense RNA viruses that have numerous biotechnological applications. However, recovering plant rhabdoviruses from cDNA remains difficult due to technical difficulties such as the need for concurrent in planta ...
Drake, P   +3 more
core   +1 more source

The sequence of Compton dominance in blazars based on data from WISE and Fermi/LAT

open access: yes, 2017
The two-component broad-band spectral energy distributions of blazars were suggested to form a sequence in which (1) the peak frequency of the low-energy (synchrotron) component nu_syn is anticorrelated with the synchrotron luminosity L_syn, and (2) the ...
Gupta, Maitrayee, Nalewajko, Krzysztof
core   +1 more source

Exact Recovery Conditions for Sparse Representations with Partial Support Information [PDF]

open access: yes, 2013
We address the exact recovery of a k-sparse vector in the noiseless setting when some partial information on the support is available. This partial information takes the form of either a subset of the true support or an approximate subset including wrong
Gribonval, R.   +3 more
core   +5 more sources

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Séquence Éviter-Réduire-Compenser : quelle biodiversité est visée par les mesures d’évitement ? [PDF]

open access: yesSciences, Eaux & Territoires, 2019
La séquence éviter-réduire-compenser a pris une importance croissante dans les politiques environnementales françaises. Mais après plus de dix ans d’application sur le terrain, le constat est partagé : la compensation accapare beaucoup d’efforts, tandis ...
GUILLET, Fanny   +2 more
doaj  

Approches anticipées et planifiées de la compensation écologique en Allemagne : vers un retour d’expérience pour la France ? [PDF]

open access: yesSciences, Eaux & Territoires, 2020
Les organisations planifiées et mutualisées de la compensation apparaissent dès la fin des années 1990 en Allemagne, soit plus de dix ans avant que la France n’adopte elle-même de telles approches.
BAS, Adeline   +6 more
doaj  

NFTs for Open-Source and Commercial Software Licensing and Royalties

open access: yesIEEE Access, 2023
Software licenses are legal agreements of sale and usage among software developers and clients. Such legal agreements are crucial to effectively manage ownership and protect the rights of involved parties. Today’s software licensing mechanisms are
Mohammad Madine   +3 more
doaj   +1 more source

Lynds 1622: a nearby star forming cloud projected on Orion B?

open access: yes, 2008
We present results of optical spectroscopic and photometric observation of the pre-main sequence stars associated with the cometary shaped dark cloud Lynds 1622, and 12CO and 13CO observations of the cloud.
A. Gáspár   +65 more
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy